Thomas Byrne
Question:1339. Deputy Thomas Byrne asked the Minister for Health when the drug Translarna will be made available to those persons for whom it is suitable as a treatment for Duchenne's muscular dystrophy. [28043/17]
View answerTuesday, 20 June 2017
Questions (1339)
Written answers
The HSE has statutory responsibility for decisions on pricing and reimbursement of medicines under the community drug schemes, in accordance with the provisions of the Health (Pricing and Supply of Medical Goods) Act 2013; therefore, the matter has been referred to the HSE for reply to the Deputy.